Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 6Sleep Apnea, Obstructive 5Sleep Apnea Syndromes 3Polycystic Ovary Syndrome 3Neoplasms 2Breast Neoplasms 2Urogenital Neoplasms 1Unilateral Breast Neoplasms 1Thrombocythemia, Essential 1Small Cell Lung Carcinoma 1Polycythemia Vera 1Obesity 1Microcephaly, Primary Autosomal Recessive, 6 1Metabolic Syndrome 1Insulin Resistance 1Glucose Intolerance 1Carcinoma, Non-Small-Cell Lung 1Abdominal Neoplasms 1

Interventions

pembrolizumab 5padeliporfin 5Nivolumab 5fludarabine 4aldesleukin 4Ipilimumab 4Cyclophosphamide 4atezolizumab 3Sunitinib 3Specimen Handling 3Paclitaxel 3Mitomycin 3Magnetic Resonance Spectroscopy 3Gemcitabine 3Drug Therapy 3Carboplatin 3Biopsy 3Abiraterone Acetate 3vedolizumab 2olaparib 2niraparib 2motexafin gadolinium 2enfortumab vedotin 2darolutamide 2cabozantinib 2anlotinib 2abiraterone 2Therapeutics 2Suspensions 2Surveys and Questionnaires 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urogenital Neoplasms × Continuous Positive Airway Pressure × Clear all
NCT07111039 2026-05-18

Compare Airway Pressure Release Ventilation (APRV) to Conventional Mechanical Ventila

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Withdrawn

Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡